Pharming Group N.V. (PHAR) Operating cash flow 2019–2025
Pharming Group N.V. (PHAR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$54.7MFY2025 · since FY2019: $74.1M → $54.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $54.7M | +3147.8% |
| FY2024 | -$1.8M | +89.6% |
| FY2023 | -$17.3M | -177.0% |
| FY2022 | $22.5M | -40.7% |
| FY2021 | $37.8M | -54.7% |
| FY2020 | $83.6M | +12.8% |
| FY2019 | $74.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice